On Demand Webinars
-
Intelligent Manufacturing Of mRNA Through The Power Of Process Analytical Technologies
3/10/2025
Learn how predictive models can monitor key CQAs, such as RNA concentration and nucleoside triphosphate consumption, and explore RBP and MIT’s vision for revolutionizing biomanufacturing.
-
New Approaches For Targeted Drug Delivery With Nanomedicines
4/13/2022
Nanomedicine is a branch of medicine that seeks to apply nanotechnology for disease prevention and/or treatment, imaging, diagnosis, monitoring, and the repair and regeneration of biological systems.
-
How mRNA Manufacturers Disrupt The Industry
3/21/2023
Learn how biopharmaceutical companies can apply proven strategies to overcome hidden complexities in mRNA production, and discover solutions that can help you rapidly design and build a SU facility.
-
Development And Regulatory Strategy For US And China
9/22/2022
This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers.
-
From Crisis To Confidence: Ensuring Smooth Regulatory Submissions
10/8/2024
Explore some of the major challenges that medical writing submission specialists face today and strategies that can consistently set the stage for success.
-
Go/No Go Decisions Based On Early Phase Oncology Trials
9/22/2022
In this webinar, gain insight into the latest regulatory and clinical developments in the field of oncology in China.
-
Overcoming Key Challenges In Vaccine Development
4/14/2022
Dive into this overview of vaccine development and learn how to overcome some key challenges with Precision NanoSystems Inc.'s field application scientist, Dr. Ian Villamagna.
-
Who's In Charge? How To Ensure Effective Trial Oversight, Leadership
3/19/2025
Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.
-
Establishing Analytical Methods For Emerging mRNA-Based Therapies
6/5/2023
Here, we describe the use of cutting-edge technologies to assess critical quality attributes of both mRNA drug substances and drug products.
-
Accelerating Clinical Development In China & The US
9/22/2022
Discover how the clinical research bridge between China and the US supports accelerated clinical development from early to late phase trials while ensuring the inclusion of MRCT data packages in future regulatory applications.